Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency.

نویسندگان

  • S H Goodnight
  • D I Feinstein
  • B Osterud
  • S I Rapaport
چکیده

S EDITOR MARIO BALDINI, Providence, R. I. BOOK REVIEW EDITOR STEPHEN H. ROBINSON, Boston, Mass. BLOOD The Journal of Hematology II Fi aicx STOHLMAN, Jn., Editor in Chief, Boston, Mass. ERNST R. JAirFE, Associate Editor New York, N. Y. WILLIAM DA .sI x , Founding Editor EDITORIAL BOARD Jom W. ATHENS, Salt Lake City, Utah MARIO BALDINI, Providence, R. I. ERNEST BEIJTLER, Duarte, Calif. DANE R. Boccs, Pittsburgh, Pa. GEORGE BRECHER, San Francisco, Calif. EUGENE P. Cmo xrrit, Upton, N. Y. CHARLES A. Doxi’ , Columbus, Ohio FRANK GARDNER, Philadelphia, Pa. ALBERT S. GORDON, New York, N. Y. SAMUEL Boston, Mass. VIcroR HERBERT, New York, N. Y. JAMES HIRSCH, New York, N. Y. KURT HIRscmsoaN, New York, N. Y. B .nm Hoocsnwm , Kansas City, Kans. HAIUW S. JACOB, Minneapolis, Minn. WALLACE N. JENSEN, Washington, D. C. JACK LEvIN, Baltimore, Md. TAKASHI MAKINODAN, Oak Ridge, Tenn. AARON MARCUS, New York, N. Y. ALVIN M. MAUER, Cincinnati, Ohio D. BAKALOS, Athens, Greece M4U CF.I. BESSIS, Paris, France HERBERT BRAUNSTEINER, Inn.sbruck, Austria J. V. DAdE, London, England LuD\TE Do rm, Prague, Czechoslovakia THEODOR M. Fu nNnm, Ulm, Germany RONALD GIBDWOOD, Edinburgh, Scotland WILLIAM C. MOLONEY, Boston, Mass. CARL V. MOORE, St. Louis, Mo. HELEN M. R t .’i, New York, N. Y. RICHARD ROSENFLELD, New York, N. 1. JOSEPH F. Ross, Los Angeles, Calif. Rum SCHMID, San Francisco, Calif. P rER H. Scmn , Boston, Mass. SANDOR S. SHAPIRO, Philadelphia, Pa. ROBERT S. Sciiw wrz, Boston, Mass. THEODORE H. Sp .arr, New York, N. Y. E. DONNALL THOMAS, Seattle, Wash. Louis WASSERMAN, New York, N. Y. ROBERT I. W , Rochester, N. Y. LEON WEISS, Baltimore, Md. MAXWELL M. WIt’rrmoBE, Salt Lake City, Utah DoRom ZUCKER-FRANXLIN, New York, N. Y. WOLF ZUELZER, Detroit, Mich. E. A. MCCULLOCH, Toronto, Canada SVEN-AACE KILLMANN, Copenhagen, Denmark PETER MIESCRER, At Large SvEN MOE5CHLIN, Solothnrn, Switzerland PAUL A. OWREN, Oslo, Norway j. ROSKAM, Liege, Belgium E. STORTI, Pavia, Italy S. I. DE VRIES, The Netherlands JAN WALDENSTR#{246}M, Malm#{246},Sweden

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preparation of factor VII concentrate using CNBr-activated

  Background: Factor VII concentrates are used in patients with congenital or acquired factor VII deficiency or treatment of hemophilia patients with inhibitors. In this research, immunoaffinity chromatography was used to purify factor VII from prothrombin complex (Prothrombin-Proconvertin-Stuart Factor-Antihemophilic Factor B or PPSB) which contains coagulation factors II, VII, IX and X. The a...

متن کامل

A case report of temporary and acquired vitamin K-dependent clotting factor deficiency without any response to administrated vitamin K

Abstract Background and Objectives Vitamin K-dependent clotting factor deficiency (VKCFD) is usually an acquired problem due to liver disease, malabsorption, and overdose of warfarin.  In the present paper the significance and role of vitamin K-dependent coagulation factors in menorrhagia were evaluated.   Case We present a rare case of 43 year woman with acquired vitamin K deficiency and se...

متن کامل

PREPARATION OF HIGHLY PURIFIED SOLVENTDETERGENT COA GULATION FACTOR VII AND FACTOR IX CONCENTRATES FROM PROTHROMBIN COMPLEX (PPSB)

In this study, anion-exchange chromatography was used to purify factor VII and factor IX from prothrombin complex (PPSB), which contains coagulation factors II, VII, IX and X. For this purpose, DEAE-Sepharose CL-6B gel , Pharmacia column XK-26 , high flow rate and two stepwise gradients with phosphate citrate buffer were used. The yield of the two lyophylized products, factor VII and factor...

متن کامل

Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-like Domain of Factor VII

Background: Coagulation Factor VII is a vitamin K-dependent serine protease which has a pivotal role in the initiation of the coagulation cascade. The congenital Factor VII deficiency is a recessive hemorrhagic disorder that occurs due to mutations of F7 gene. In the present study C91S (p.C91S) substitution was detected in a patient with FVII deficiency. This mutation has not b...

متن کامل

Jaundice and factor VII deficiency in newborn

Resistance to thyroid hormone is an uncommon condition. We report the clinical and laboratory findings of a case with both resistance to thyroid hormone and, a reduced capacity to produce and respond to thyroid hormone. RTH is a disorder characterized by elevated circulating thyroid hormones, state of non-suppressed pituitary TSH secretion and refractoriness to hormone action in peripheral tiss...

متن کامل

Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications

Coagulation factors belong to a family of plasma glycosylated proteins that should be activated for appropriate blood coagulation. Congenital deficiencies of these factors cause inheritable hemorrhagic diseases. Factor VII (FVII) deficiency is a rare bleeding disorder with variable clinical symptoms. Various mutations have been identified throughout the F7 gene and can affect all the protein do...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Blood

دوره 38 1  شماره 

صفحات  -

تاریخ انتشار 1971